Copeptin in Aortic Valve Replacement

GE DHM-AN-OR-2012/01

NCT01648647•Deutsches Herzzentrum Muenchen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Copeptin in Patients Undergoing Aortic Valve Replacement

Locations

Germany

Locations (1)

Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München

Munich, Bavaria, Germany

Key Dates

Start Date

May 1, 2012

Last Updated

July 24, 2012

Sponsors

Lead Sponsor

Deutsches Herzzentrum Muenchen

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions